Qube Research & Technologies (QRT)
ACLX

Qube Research & Technologies (QRT)’s Arcellx ACLX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.9M Buy
303,847
+205,941
+210% +$18.2M 0.04% 579
2025
Q4 		$6.38M Buy
+97,906
New +$7.81M 0.01% 1629
2025
Q3 		– Sell
-11,772
Closed -$775K – 3529
2025
Q2 		$775K Sell
11,772
-161,287
-93% -$10M ﹤0.01% 2558
2025
Q1 		$11.4M Buy
173,059
+18,659
+12% +$1.26M 0.01% 1053
2024
Q4 		$11.8M Buy
154,400
+104,149
+207% +$9M 0.02% 992
2024
Q3 		$4.2M Sell
50,251
-94,385
-65% -$6.29M 0.01% 1470
2024
Q2 		$7.98M Buy
144,636
+43,450
+43% +$2.36M 0.01% 1037
2024
Q1 		$7.04M Buy
101,186
+87,261
+627% +$5.53M 0.01% 1035
2023
Q4 		$773K Buy
+13,925
New +$628K ﹤0.01% 2062
2023
Q3 		– Sell
-110,744
Closed -$3.5M – 4061
2023
Q2 		$3.5M Buy
+110,744
New +$4.23M 0.01% 827

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACLX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Arcellx (ACLX) stake by 210% in Q1 2026, buying an estimated $18.2M and bringing the position to 303,847 shares worth $34.9M. The position accounts for 0.04% of the portfolio, ranked #579.

Qube Research & Technologies (QRT) first reported a position in ACLX in Q2 2023 and has held it in 10 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 303,847 shares of Arcellx worth $34.9M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 205,941 Arcellx shares in Q1 2026, an estimated $18.2M.
  • Arcellx made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #579 holding.
  • Qube Research & Technologies (QRT) first reported a position in Arcellx in Q2 2023 and has held it in 10 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.